| ■ 영문 제목 : Global anti-HA Antibody Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2108K200011 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 166 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 항-HA 항체의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (IgM , IgG, IgA, 기타)와 용도별 시장규모 (치료, 연구, 진단) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 항-HA 항체 시장 점유율 - 지역별 항-HA 항체 시장규모 - 주요지역의 종류별 시장규모 (IgM , IgG, IgA, 기타) - 주요지역의 용도별 시장규모 (치료, 연구, 진단) - 미주의 항-HA 항체 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 항-HA 항체 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 항-HA 항체 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 항-HA 항체 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 항-HA 항체 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2020 growth of anti-HA Antibody will have significant change from previous year. By the most conservative estimates of global anti-HA Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the anti-HA Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of anti-HA Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
IgM
IgG
IgA
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Therapeutic
Research
Diagnostic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
1 Scope of the Report 2 Executive Summary 3 Global anti-HA Antibody by Company 4 anti-HA Antibody by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global anti-HA Antibody Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. anti-HA Antibody Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of IgM Table 3. Major Players of IgG Table 4. Major Players of IgA Table 5. Major Players of Other Table 6. Global anti-HA Antibody Sales by Type (2016-2021) & (K Doses) Table 7. Global anti-HA Antibody Sales Market Share by Type (2016-2021) Table 8. Global anti-HA Antibody Revenue by Type (2016-2021) & ($ million) Table 9. Global anti-HA Antibody Revenue Market Share by Type (2016-2021) Table 10. Global anti-HA Antibody Sale Price by Type (2016-2021) Table 11. Global anti-HA Antibody Sales by Application (2016-2021) & (K Doses) Table 12. Global anti-HA Antibody Sales Market Share by Application (2016-2021) Table 13. Global anti-HA Antibody Value by Application (2016-2021) Table 14. Global anti-HA Antibody Revenue Market Share by Application (2016-2021) Table 15. Global anti-HA Antibody Sale Price by Application (2016-2021) Table 16. Global anti-HA Antibody Sales by Company (2019-2021) & (K Doses) Table 17. Global anti-HA Antibody Sales Market Share by Company (2019-2021) Table 18. Global anti-HA Antibody Revenue by Company (2019-2021) ($ Millions) Table 19. Global anti-HA Antibody Revenue Market Share by Company (2019-2021) Table 20. Global anti-HA Antibody Sale Price by Company (2019-2021) Table 21. Key Manufacturers anti-HA Antibody Producing Area Distribution and Sales Area Table 22. Players anti-HA Antibody Products Offered Table 23. anti-HA Antibody Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global anti-HA Antibody Sales by Region (2016-2021) (K Doses) Table 27. Global anti-HA Antibody Sales Market Share by Region (2016-2021) Table 28. Global anti-HA Antibody Revenue by Region (2016-2021) & ($ Millions) Table 29. Global anti-HA Antibody Revenue Market Share by Region (2016-2021) Table 30. Americas anti-HA Antibody Sales by Country (2016-2021) & (K Doses) Table 31. Americas anti-HA Antibody Sales Market Share by Country (2016-2021) Table 32. Americas anti-HA Antibody Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas anti-HA Antibody Revenue Market Share by Country (2016-2021) Table 34. Americas anti-HA Antibody Sales by Type (2016-2021) & (K Doses) Table 35. Americas anti-HA Antibody Sales Market Share by Type (2016-2021) Table 36. Americas anti-HA Antibody Sales by Application (2016-2021) & (K Doses) Table 37. Americas anti-HA Antibody Sales Market Share by Application (2016-2021) Table 38. APAC anti-HA Antibody Sales by Region (2016-2021) & (K Doses) Table 39. APAC anti-HA Antibody Sales Market Share by Region (2016-2021) Table 40. APAC anti-HA Antibody Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC anti-HA Antibody Revenue Market Share by Region (2016-2021) Table 42. APAC anti-HA Antibody Sales by Type (2016-2021) & (K Doses) Table 43. APAC anti-HA Antibody Sales Market Share by Type (2016-2021) Table 44. APAC anti-HA Antibody Sales by Application (2016-2021) & (K Doses) Table 45. APAC anti-HA Antibody Sales Market Share by Application (2016-2021) Table 46. Europe anti-HA Antibody Sales by Country (2016-2021) & (K Doses) Table 47. Europe anti-HA Antibody Sales Market Share by Country (2016-2021) Table 48. Europe anti-HA Antibody Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe anti-HA Antibody Revenue Market Share by Country (2016-2021) Table 50. Europe anti-HA Antibody Sales by Type (2016-2021) & (K Doses) Table 51. Europe anti-HA Antibody Sales Market Share by Type (2016-2021) Table 52. Europe anti-HA Antibody Sales by Application (2016-2021) & (K Doses) Table 53. Europe anti-HA Antibody Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa anti-HA Antibody Sales by Country (2016-2021) & (K Doses) Table 55. Middle East & Africa anti-HA Antibody Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa anti-HA Antibody Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa anti-HA Antibody Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa anti-HA Antibody Sales by Type (2016-2021) & (K Doses) Table 59. Middle East & Africa anti-HA Antibody Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa anti-HA Antibody Sales by Application (2016-2021) & (K Doses) Table 61. Middle East & Africa anti-HA Antibody Sales Market Share by Application (2016-2021) Table 62. Global anti-HA Antibody Sales Forecast by Type (2021-2026) & (K Doses) Table 63. Global anti-HA Antibody Sales Market Share Forecast by Type (2021-2026) Table 64. Global anti-HA Antibody Revenue Forecast by Type (2021-2026) & ($ Millions) Table 65. Global anti-HA Antibody Revenue Market Share Forecast by Type (2021-2026) Table 66. Global anti-HA Antibody Sales Forecast by Application (2021-2026) & (K Doses) Table 67. Global anti-HA Antibody Sales Market Share Forecast by Application (2021-2026) Table 68. Global anti-HA Antibody Revenue Forecast by Application (2021-2026) & ($ Millions) Table 69. Global anti-HA Antibody Revenue Market Share Forecast by Application (2021-2026) Table 70. Roche Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 71. Roche anti-HA Antibody Product Offered Table 72. Roche anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 73. Roche Main Business Table 74. Roche Latest Developments Table 75. Johnson & Johnson Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 76. Johnson & Johnson anti-HA Antibody Product Offered Table 77. Johnson & Johnson anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 78. Johnson & Johnson Main Business Table 79. Johnson & Johnson Latest Developments Table 80. Merck Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 81. Merck anti-HA Antibody Product Offered Table 82. Merck anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 83. Merck Main Business Table 84. Merck Latest Developments Table 85. Novartis Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 86. Novartis anti-HA Antibody Product Offered Table 87. Novartis anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 88. Novartis Main Business Table 89. Novartis Latest Developments Table 90. AbbVie Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 91. AbbVie anti-HA Antibody Product Offered Table 92. AbbVie anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 93. AbbVie Main Business Table 94. AbbVie Latest Developments Table 95. Amgen Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 96. Amgen anti-HA Antibody Product Offered Table 97. Amgen anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 98. Amgen Main Business Table 99. Amgen Latest Developments Table 100. Pfizer Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 101. Pfizer anti-HA Antibody Product Offered Table 102. Pfizer anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 103. Pfizer Main Business Table 104. Pfizer Latest Developments Table 105. Bayer Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 106. Bayer anti-HA Antibody Product Offered Table 107. Bayer anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 108. Bayer Main Business Table 109. Bayer Latest Developments Table 110. Lilly Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 111. Lilly anti-HA Antibody Product Offered Table 112. Lilly anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 113. Lilly Main Business Table 114. Lilly Latest Developments Table 115. Bristol-Myers Squibb Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 116. Bristol-Myers Squibb anti-HA Antibody Product Offered Table 117. Bristol-Myers Squibb anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 118. Bristol-Myers Squibb Main Business Table 119. Bristol-Myers Squibb Latest Developments Table 120. GlaxoSmithKline Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 121. GlaxoSmithKline anti-HA Antibody Product Offered Table 122. GlaxoSmithKline anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 123. GlaxoSmithKline Main Business Table 124. GlaxoSmithKline Latest Developments Table 125. Biogen Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 126. Biogen anti-HA Antibody Product Offered Table 127. Biogen anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 128. Biogen Main Business Table 129. Biogen Latest Developments Table 130. AstraZeneca Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 131. AstraZeneca anti-HA Antibody Product Offered Table 132. AstraZeneca anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 133. AstraZeneca Main Business Table 134. AstraZeneca Latest Developments Table 135. Sanofi Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 136. Sanofi anti-HA Antibody Product Offered Table 137. Sanofi anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 138. Sanofi Main Business Table 139. Sanofi Latest Developments Table 140. Alexion Pharmaceuticals Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 141. Alexion Pharmaceuticals anti-HA Antibody Product Offered Table 142. Alexion Pharmaceuticals anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 143. Alexion Pharmaceuticals Main Business Table 144. Alexion Pharmaceuticals Latest Developments Table 145. Seattle Genetics Basic Information, anti-HA Antibody Manufacturing Base, Sales Area and Its Competitors Table 146. Seattle Genetics anti-HA Antibody Product Offered Table 147. Seattle Genetics anti-HA Antibody Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 148. Seattle Genetics Main Business Table 149. Seattle Genetics Latest Developments List of Figures Figure 1. Picture of anti-HA Antibody Figure 2. anti-HA Antibody Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global anti-HA Antibody Sales Growth Rate 2016-2026 (K Doses) Figure 7. Global anti-HA Antibody Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. anti-HA Antibody Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of IgM Figure 10. Product Picture of IgG Figure 11. Product Picture of IgA Figure 12. Product Picture of Other Figure 13. Global anti-HA Antibody Sales Market Share by Type in 2020 Figure 14. Global anti-HA Antibody Revenue Market Share by Type (2016-2021) Figure 15. anti-HA Antibody Consumed in Therapeutic Figure 16. Global anti-HA Antibody Market: Therapeutic (2016-2021) & (K Doses) Figure 17. anti-HA Antibody Consumed in Research Figure 18. Global anti-HA Antibody Market: Research (2016-2021) & (K Doses) Figure 19. anti-HA Antibody Consumed in Diagnostic Figure 20. Global anti-HA Antibody Market: Diagnostic (2016-2021) & (K Doses) Figure 21. Global anti-HA Antibody Sales Market Share by Application (2016-2021) Figure 22. Global anti-HA Antibody Revenue Market Share by Application in 2020 Figure 23. Global anti-HA Antibody Revenue Market by Company in 2020 ($ Million) Figure 24. Global anti-HA Antibody Revenue Market Share by Company in 2020 Figure 25. Global anti-HA Antibody Sales Market Share by Regions (2016-2021) Figure 26. Global anti-HA Antibody Revenue Market Share by Region in 2020 Figure 27. Americas anti-HA Antibody Sales 2016-2021 (K Doses) Figure 28. Americas anti-HA Antibody Revenue 2016-2021 ($ Millions) Figure 29. APAC anti-HA Antibody Sales 2016-2021 (K Doses) Figure 30. APAC anti-HA Antibody Revenue 2016-2021 ($ Millions) Figure 31. Europe anti-HA Antibody Sales 2016-2021 (K Doses) Figure 32. Europe anti-HA Antibody Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa anti-HA Antibody Sales 2016-2021 (K Doses) Figure 34. Middle East & Africa anti-HA Antibody Revenue 2016-2021 ($ Millions) Figure 35. Americas anti-HA Antibody Sales Market Share by Country in 2020 Figure 36. Americas anti-HA Antibody Revenue Market Share by Country in 2020 Figure 37. Americas anti-HA Antibody Sales Market Share by Type in 2020 Figure 38. Americas anti-HA Antibody Sales Market Share by Application in 2020 Figure 39. United States anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC anti-HA Antibody Sales Market Share by Region in 2020 Figure 44. APAC anti-HA Antibody Revenue Market Share by Regions in 2020 Figure 45. APAC anti-HA Antibody Sales Market Share by Type in 2020 Figure 46. APAC anti-HA Antibody Sales Market Share by Application in 2020 Figure 47. China anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 51. India anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe anti-HA Antibody Sales Market Share by Country in 2020 Figure 54. Europe anti-HA Antibody Revenue Market Share by Country in 2020 Figure 55. Europe anti-HA Antibody Sales Market Share by Type in 2020 Figure 56. Europe anti-HA Antibody Sales Market Share by Application in 2020 Figure 57. Germany anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 58. France anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 59. UK anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa anti-HA Antibody Sales Market Share by Country in 2020 Figure 63. Middle East & Africa anti-HA Antibody Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa anti-HA Antibody Sales Market Share by Type in 2020 Figure 65. Middle East & Africa anti-HA Antibody Sales Market Share by Application in 2020 Figure 66. Egypt anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country anti-HA Antibody Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles |
| ※본 조사보고서 [세계의 항-HA 항체 시장예측 2021년-2026년] (코드 : LPI-2108K200011) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 항-HA 항체 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |